RnetHealth.com Names New Members to Board of Advisors; Leading Names In Communications, Direct-to-Consumer Marketing, and Media Round Out Clinical Advisory Board.

Business Editors/Health & Medical Writers

SANTA MONICA, Calif.--(BUSINESS WIRE)--Aug. 8, 2000

RnetHealth.com, Inc. (OTCBB:RNET) today announced the appointment of three new members to its Advisory Board, which includes some of the leading national names in behavioral health care. Chaired by Mark S. Gold, M.D., (Professor at the University of Florida College of Medicine's Brain Institute, Departments of Neuroscience, Psychiatry, Community Health & Family Medicine), the Advisory Board provides leading content and oversight to RnetHealth.com's Internet, radio and TV media. The new members round out the scientific expertise of the Board's current members with expertise in media and advertising production and programming.

The new Advisory Board members are:

Joyce Fiory heads her own Chicago-based communications firm, Communications for Business & Health. Previously, Joyce was director of public affairs at the American College of Healthcare Executives, where she started Healthcare Executive magazine. Joyce has also served as editor of Hospital & Health Services Administration, Healthcare Human Resources and Healthcare QI Training Report. She is a contributing editor to Strategic Healthcare Marketing and Medicine on the Net. She launched Internet Healthcare Strategies, a new monthly publication for Santa Barbara, CA-based COR Health ([e-mail]) in October 1999. Joyce's many clients have included Crain Communications, Modern Healthcare, American Hospital Publishing, Lamalie Amrop, the American Association of Healthcare Consultants, and ServiceMaster. She is the co-author of five books on the Internet published by Irwin/McGraw-Hill in 1997, including The Online Business Guide to Financial Services, The Online Guide to Healthcare and Wellness, and The Online Guide to Healthcare Management and Medicine. She is also the author of the Healthcare Guide to the Internet, which is published quarterly by COR Research, Santa Barbara, California, as well as the Directory of Healthcare Organizations on the Internet, which is published annually. She has spoken on the Internet to groups as diverse as IBC Conferences, International Quality and Productivity Center, the Healthcare Strategy Institute, MVP Productions, the Alliance for Healthcare Strategy and Marketing, the National Patient Education Conference, the New Jersey Hospital Association, the New Jersey Healthcare Congress, the Alliance for Healthcare Strategy and Market Development, the Illinois Hospital Association, Parke-Davis, the National Association for Healthcare Quality, e-Healthcare World, and the e-Healthcare Tour. She has held teaching positions at the University of Minnesota, Duluth, and at Northeastern Illinois University, Chicago. Joyce holds a Ph.D. in communications from Indiana University, Bloomington, and is active in a variety of professional organizations, including the Society for Healthcare Planning and Marketing and the National Speaker's Association. Joyce serves on the advisory boards for E-Healthcare World and the e-Healthcare Association.

James Sandino is President of Lowe Consumer Healthcare, a joint venture of Lowe Healthcare Worldwide and Lowe & Partners formed to focus on the rapidly expanding field of direct-to-consumer (DTC) marketing of prescription drugs, as well as related medical and healthcare products. Sandino is a nationally recognized leader in the development of DTC marketing and communications programs for healthcare and pharmaceutical companies. He developed the first use of Direct Response TV for a prescription product for Upjohn's Rogaine and developed a Direct Response TV campaign for the first FDA-approved use of a switch from non-brand-specific ad to branded fulfillment for Merck's Proscar. He created award-winning relationship marketing programs for hypertension and hypercholesterolemia indications for Bristol-Myers Squibb and served as Senior Strategic DTC Consultant for Glaxo Wellcome. His previous consumer brand experience includes work with Columbia House, AT&T, Prodigy, Time-Life Books, Sports Illustrated, Coca-Cola, American Express, and the 1984 Olympics. Sandino designed and orchestrated the DTC launch for Lamisil Tablets, and Roche's acne DTC campaign, two of the most successful programs fielded to date. He developed the first half-hour healthcare program to run "prime-time" for physicians and consumers. He was selected as one of the year's most innovative experts in television by Response TV magazine and serves on the Advisory Board for eHealthcare World.

Charlotte Schiff-Jones has been an award-winning entertainment and publishing executive who has balanced her work life with a focus on social issues. Currently President and General Manager for Hylan Booker Couture, Schiff-Jones was previously Owner and President of Gamut Media, a strategic marketing and programming company that specialized in new program networks and technology for cable television. Clients included MTV Networks, USA Networks and Time Warner. Schiff-Jones also served as a consultant to the president and CEO of Time Warner Cable Programming, evaluating proposals for new ventures and networks, and headed up her own consulting firm, Schiff-Jones Ltd., which specialized in analysis, strategic marketing and programming for clients such as Granada (England), Viacom, The Visa Group, Playboy Enterprises, CBS and Time Warner. Earlier in her career, she was Executive Vice President/Director of Manhattan Cable, a division of Time, Inc., Associate Publisher/General Manager of People Magazine, Creator and Producer of the "People" television series on CBS for Time Life Television, and Founder and Senior Vice President of CBS Cable, the first cultural and performing arts network. Until recently, Schiff-Jones served on the Board of Directors of RnetHealth.com, Inc.

The new advisors join chair Dr. Mark Gold and current advisors:

Dr. Robert DuPont is President of the Institute for Behavior and Health in Rockville, Maryland and Clinical Professor of Psychiatry at Georgetown University School of Medicine.

Jan Fawcett, M.D. is Chairman of the Department of Psychiatry at Rush-Presbyterian-St. Luke's Medical Center and an expert on the biomedical aspects of depression and suicide.

Douglas E. Goldstein is a widely recognized global e-Healthcare strategist and author. He is President of eHealthcare.net (www.ehealthcare.net) and Chairman of the Newsof Group (www.newsof.com) both organizations are dedicated to innovative e-Healthcare business and product development through the appropriate use of Internet technology.

John Gums, Pharm.D. is Professor of Pharmacy and Medicine in the Departments of Pharmacy Practice and Family Medicine, Director of Clinical Pharmacy Education in Family Medicine, and Director of the Family Medicine Pharmacokinetic Laboratory at the University of Florida.

Elson M. Haas, M.D. practices Integrated Medicine and is founder and director of the Preventive Medical Center of Marin, San Rafael, California.

Richard P. Keeling, M.D. is Chief Executive Officer of Rethinkinc, a new corporation that creates health information management solutions to enhance health and transform health care for young people.

Dr. Herbert Kleber is Professor of Psychiatry and Director of the Division on Substance Abuse at Columbia University and the New York State Psychiatric Institute, Executive Vice President and Medical Director of CASA - The National Center on Addiction and Substance Abuse - and a pioneer in the research and treatment of narcotic and cocaine abuse for over 30 years.

David Pickar, M.D., formerly Chief of the Experimental Therapeutics Branch, National Institute of Mental Health, National Institutes of Health, is currently the Senior Executive Vice President and Chief Science Officer of Comprehensive NeuroScience, Inc. and a clinical professor of psychiatry at Uniformed Services University of Health Sciences.

Dr. David Smith is Founder, President and Medical Director of the Haight Ashbury Free Clinics, Associate Professor - U.C.S.F. Medical School, Medical Director - California Alcohol and Drug Program, and Founder and Executive Editor of the Journal of Psychoactive Drugs.

Barry Stimmel, M.D. is Dean for Graduate Medical Education and Professor of Medicine and Professor of Medical Education at Mt. Sinai School of Medicine and an active member of the Cardiovascular Institute. Dr. Stimmel has avidly pursued three major interests: internal medicine and cardiology, medical education, and substance abuse, and is nationally and internationally known for his role in treating and defining the pathophysiology of heroin dependency,

Andrew Lawrence Stoll, M.D. is an Assistant Professor of Psychiatry at Harvard Medical School and is the Director of the Psychopharmacology Research Laboratory at McLean Hospital.

Aida C. Vega, M.D. is the Director of Park Avenue Internal Medicine Center at the University of Florida College of Medicine. A graduate of New York University and Boston University School of Medicine, she is Board Certified in Internal Medicine.

Meg Walsh is currently CEO of Oncology.com and former president of Medscape's Consumer Division CBS HealthWatch.

Stuart Yudofsky, M.D. is the DC and Irene Ellwood Professor and Chairman, Department of Psychiatry, Baylor College of Medicine, and chief of Psychiatry Service, The Methodist Hospital, both in Houston, Texas. Dr. Yudofsky's area of academic interest is biologic psychiatry, particularly neuropsychiatry which focuses on the psychiatric aspects of neurologic illnesses in head injury, Alzheimer's disease, stroke and seizure disorder.

Wendy Borow-Johnson, President and CEO of RnetHealth.com, stated, "I am very pleased with the composition of the Advisory Board and the additions of Ms. Schiff-Jones, Ms. Fiory and Mr. Sandino furthers the Company's commitment to building the strongest cross-media platform in this space."

About RnetHealth.com

RnetHealth.com, Inc. (OTCBB:RNET) (the "Company") is a digital media company leveraging the converging digital technologies of the Internet (www.rnethealth.com) and television (Recovery Network) to deliver traditional and alternative behavioral health interactive intervention and self-help programs, community and e-care to consumers, businesses and their employees.

Recovery Network is a satellite delivered television network reaching approximately 7 million cable households.

The Internet component -- www.rnethealth.com -- provides a branded, integrated, Web-based solution via a public platform for consumers, as well as a business to business platform for the behavioral healthcare needs of employees, employers, insurance companies, managed care organizations, health care systems, providers, universities and other organized communities. The Company is the behavioral health resource for America Online's Digital City, Inc., the No. 1 local online city guide network. RnetHealth.com receives branding on AOL/DCI and direct links from AOL-DCI to the RnetHealth.com web site.

The company's primary market is individuals whose lives are impacted by behavioral health issues (e.g., eating disorders, depression, substance abuse, stress, anxiety, etc.) as well as by the chronic diseases associated with behavioral health issues (including cancer, heart disease, hypertension, asthma, diabetes, hepatitis, and others). The company provides action plans for traditional forms of treatment, as well as clinically based alternative and complementary health solutions.

RnetHealth.com's efforts are uniquely integrated with leading nonprofit behavioral health care organizations. The Company's National Partnership for Recovery and Prevention (NPRP) consists of over 50 prominent national health, support, recovery and prevention organizations that represent over 40 million people throughout the United States.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions, and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.